The Section Board Established
The Board of the EFB Section on Medicines Development was established at a meeting in Brussels on 4th and 5th March, 2004.
The Board consists of the following members:
Jørgen Dirach, Novo Nordisk (Chairman), Denmark
Lilia Alberghina, University of Milano-Bicocca, Italy
Jaime Algorta, Leia, Spain
Anders Åkerlund, Astra Zeneca, Sweden/UK
Iman Barilero, Johnson & Johnson Pharmaceutical Research and Development, UK
Alberico Catapano, University of Milano, Pharmacology, Italy
Türkan Eldem, Hacettepe University, Turkey
Paul M Foely, Geneering GmbH, Germany
Stephen Little, DxS Ltd., UK
Andreani Odysseos, University of Cyprus, Cyprus
Ysbrand Poortman, European Platform for Patients' Organisations, Science and Industry (EPPOSI), The Netherlands
Menno van der Waart, NV Organon, The Netherlands
It was agreed to keep seats open on the Board for a few additional, relevant stakeholders.
Participants in the establishing Board meeting of the EFB Section on Medicines Development.